The pediatric heart valve repair and replacement market size has grown steadily in recent years. It will grow from $3.47 billion in 2025 to $3.56 billion in 2026 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to rising burden of congenital heart defects in neonatal and pediatric populations, growing availability of surgical heart valve repair techniques, increasing pediatric cardiac surgeries in hospital-based cath labs, early clinical adoption of mechanical and bioprosthetic pediatric valves, expansion of specialized pediatric cardiology and cardiac surgery centers.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter pediatric valve interventions, rising focus on long-term valve performance and reintervention reduction, growing treatment volumes across atresia and arrhythmia indications, expanding access to pediatric cardiac care in emerging regions, increasing investment in pediatric-specific heart valve design and durability research. Major trends in the forecast period include rising adoption of pediatric heart valve repair procedures for congenital cardiac disorders, increasing utilization of mechanical and bioprosthetic valves in pediatric valve replacement, growing preference for minimally invasive and catheter-based valve repair techniques, expansion of tavi-based interventions in complex pediatric valve conditions, increasing clinical focus on long-term durability and growth-compatible pediatric valve solutions.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births - approximately 40,000 infants - each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company’s transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2025. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric heart valve repair and replacement market by increasing import and component costs for precision metals, biologic valve materials, catheter devices, and surgical hardware used across repair systems, mechanical valves, bioprosthetic valves, and TAVI devices, thereby raising manufacturing and procurement expenses for hospitals and cardiac catheterization labs. The impact is most pronounced in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing for pediatric cardiac implants and catheter-based systems, particularly within congenital heart defect and atresia treatment segments. These higher landed costs have slowed capital purchasing cycles in price-sensitive facilities; however, tariffs are also encouraging localized production partnerships, regional component sourcing, and selective innovation in cost-optimized pediatric valve technologies.
The pediatric heart valve repair and replacement market research report is one of a series of new reports that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pediatric heart valve repair and replacement market size is expected to see steady growth in the next few years. It will grow to $3.97 billion in 2030 at a compound annual growth rate (CAGR) of 2.8%. The growth in the forecast period can be attributed to increasing demand for minimally invasive and transcatheter pediatric valve interventions, rising focus on long-term valve performance and reintervention reduction, growing treatment volumes across atresia and arrhythmia indications, expanding access to pediatric cardiac care in emerging regions, increasing investment in pediatric-specific heart valve design and durability research. Major trends in the forecast period include rising adoption of pediatric heart valve repair procedures for congenital cardiac disorders, increasing utilization of mechanical and bioprosthetic valves in pediatric valve replacement, growing preference for minimally invasive and catheter-based valve repair techniques, expansion of tavi-based interventions in complex pediatric valve conditions, increasing clinical focus on long-term durability and growth-compatible pediatric valve solutions.
The rising prevalence of congenital heart defects is anticipated to drive the growth of the pediatric heart valve repair and replacement market in the future. A congenital heart defect (CHD) refers to an abnormality in the heart's structure that is present at birth. Pediatric heart valve repair and replacement are utilized in treating congenital heart defects to enhance heart function, improve the overall health of the child, prevent complications, and enhance the quality of life for those affected. For example, in October 2024, reports from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that heart defects impact nearly 1% of births - approximately 40,000 infants - each year in the United States. About 1 in 4 babies with a heart defect are diagnosed with a critical heart defect. In 2023, a baby was born with a heart defect in America every 15 minutes. Therefore, the increasing incidence of congenital heart defects is expected to stimulate growth in the pediatric heart valve repair and replacement market.
Major companies within the pediatric heart valve repair and replacement industry are embracing a strategic partnership approach to deliver customized solutions that cater to the distinct requirements of pediatric cardiac care. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in August 2023, PolyVascular Inc., a US-based medical technology manufacturer, joined forces with CobiCure, a US-based not-for-profit organization focused on pediatric care. Through this collaboration, their aim is to advance pediatric heart valve repair by offering a tailored, non-surgical approach to address congenital heart defects in children. By eliminating the need for multiple open-heart surgeries as children outgrow traditional valves, they seek to minimize associated complications and enhance patient outcomes.
In July 2024, Edwards Lifesciences, a medical technology company based in the US, acquired Innovalve Bio Medical Ltd. for an undisclosed sum. This acquisition is intended to enhance the company’s transcatheter mitral valve replacement (TMVR) technologies to address significant unmet needs among structural heart patients and support sustainable long-term growth. Innovalve Bio Medical Ltd. is an Israel-based developer of TMVR technology and cardiac valves.
Major companies operating in the pediatric heart valve repair and replacement market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Edwards Lifesciences Corporation, Artivion Inc., CryoLife Inc., LivaNova PLC, TTK Healthcare Limited, Braile Biomedica Ltda., Micro Interventional Devices Inc., Xeltis AG, Auto Tissue Berlin GmbH, BioStable Science and Engineering Inc., Colibri Heart Valve LLC, Valcare Medical, Symetis SA, On-X Life Technologies Holdings Inc., JenaValve Technology Inc., Meril Life Sciences Pvt. Ltd.
North America was the largest region in the pediatric heart valve repair and replacement market in 2025. The regions covered in the pediatric heart valve repair and replacement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric heart valve repair and replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric heart valve repair and replacement market by increasing import and component costs for precision metals, biologic valve materials, catheter devices, and surgical hardware used across repair systems, mechanical valves, bioprosthetic valves, and TAVI devices, thereby raising manufacturing and procurement expenses for hospitals and cardiac catheterization labs. The impact is most pronounced in North America, Europe, and Asia-Pacific regions that rely on cross-border sourcing for pediatric cardiac implants and catheter-based systems, particularly within congenital heart defect and atresia treatment segments. These higher landed costs have slowed capital purchasing cycles in price-sensitive facilities; however, tariffs are also encouraging localized production partnerships, regional component sourcing, and selective innovation in cost-optimized pediatric valve technologies.
The pediatric heart valve repair and replacement market research report is one of a series of new reports that provides pediatric heart valve repair and replacement market statistics, including pediatric heart valve repair and replacement industry global market size, regional shares, competitors with a pediatric heart valve repair and replacement market share, detailed pediatric heart valve repair and replacement market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric heart valve repair and replacement industry. This pediatric heart valve repair and replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Pediatric heart valve repair and replacement encompass medical procedures and technologies utilized to address heart valve issues in children, particularly targeting congenital or acquired heart valve disorders. These procedures are essential for treating conditions such as congenital heart defects, heart muscle disease, arrhythmias, and atresia.
The primary products in pediatric heart valve repair and replacement include heart valve repair, mechanical heart valves, bioprosthetic heart valves, and transcatheter aortic valve implantation (TAVI). Heart valve repair involves restoring the normal function of a malfunctioning heart valve through medical intervention. This procedure is indicated for various cardiac disorders, including congenital heart defects, heart muscle disease, atresia, arrhythmias, among others. The end-users of these products typically include hospitals, independent cardiac catheterization labs, and ambulatory surgical centers.
The pediatric heart valve repair and replacement market includes revenues earned by providing services such as diagnosis and evaluation, treatment planning, medical management, surgical intervention and surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric heart valve repair and replacement market also consists of sales of biological valves, postoperative monitoring devices, sutures and repair materials, annuloplasty rings and bands, and annuloplasty rings and bands. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pediatric Heart Valve Repair and Replacement Market Characteristics
3. Pediatric Heart Valve Repair and Replacement Market Supply Chain Analysis
4. Global Pediatric Heart Valve Repair and Replacement Market Trends and Strategies
5. Pediatric Heart Valve Repair and Replacement Market Analysis of End Use Industries
7. Global Pediatric Heart Valve Repair and Replacement Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pediatric Heart Valve Repair and Replacement Total Addressable Market (TAM) Analysis for the Market
9. Pediatric Heart Valve Repair and Replacement Market Segmentation
10. Pediatric Heart Valve Repair and Replacement Market Regional and Country Analysis
11. Asia-Pacific Pediatric Heart Valve Repair and Replacement Market
12. China Pediatric Heart Valve Repair and Replacement Market
13. India Pediatric Heart Valve Repair and Replacement Market
14. Japan Pediatric Heart Valve Repair and Replacement Market
15. Australia Pediatric Heart Valve Repair and Replacement Market
16. Indonesia Pediatric Heart Valve Repair and Replacement Market
17. South Korea Pediatric Heart Valve Repair and Replacement Market
18. Taiwan Pediatric Heart Valve Repair and Replacement Market
19. South East Asia Pediatric Heart Valve Repair and Replacement Market
20. Western Europe Pediatric Heart Valve Repair and Replacement Market
21. UK Pediatric Heart Valve Repair and Replacement Market
22. Germany Pediatric Heart Valve Repair and Replacement Market
23. France Pediatric Heart Valve Repair and Replacement Market
24. Italy Pediatric Heart Valve Repair and Replacement Market
25. Spain Pediatric Heart Valve Repair and Replacement Market
26. Eastern Europe Pediatric Heart Valve Repair and Replacement Market
27. Russia Pediatric Heart Valve Repair and Replacement Market
28. North America Pediatric Heart Valve Repair and Replacement Market
29. USA Pediatric Heart Valve Repair and Replacement Market
30. Canada Pediatric Heart Valve Repair and Replacement Market
31. South America Pediatric Heart Valve Repair and Replacement Market
32. Brazil Pediatric Heart Valve Repair and Replacement Market
33. Middle East Pediatric Heart Valve Repair and Replacement Market
34. Africa Pediatric Heart Valve Repair and Replacement Market
36. Pediatric Heart Valve Repair and Replacement Market Competitive Landscape and Company Profiles
37. Pediatric Heart Valve Repair and Replacement Market Other Major and Innovative Companies
40. Pediatric Heart Valve Repair and Replacement Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pediatric Heart Valve Repair And Replacement Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pediatric heart valve repair and replacement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric heart valve repair and replacement? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric heart valve repair and replacement market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Heart Valve Repair; Mechanical Heart Valves; Bioprosthetic Heart Valves; Transcatheter Aortic Valve Implantation (TAVI)2) By Indication: Congenital Heart Defects; Heart Muscle Disease; Atresia; Arrhythmias; Other Cardiac Disorders
3) By End-User: Hospitals; Independent Cardiac Catheterization Labs; Ambulatory Surgical Centers
Subsegments:
1) By Heart Valve Repair: Surgical Repair Techniques; Catheter-Based Repair Techniques2) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Other Mechanical Valves
3) By Bioprosthetic Heart Valves: Porcine Valves; Bovine Valves; Other Bioprosthetic Valves
4) By Transcatheter Aortic Valve Implantation (TAVI): Balloon-Expandable Valves; Self-Expanding Valves; Other TAVI Devices
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Lepu Medical Technology (Beijing) Co. Ltd.; Edwards Lifesciences Corporation; Artivion Inc.; CryoLife Inc.; LivaNova PLC; TTK Healthcare Limited; Braile Biomedica Ltda.; Micro Interventional Devices Inc.; Xeltis AG; Auto Tissue Berlin GmbH; BioStable Science and Engineering Inc.; Colibri Heart Valve LLC; Valcare Medical; Symetis SA; On-X Life Technologies Holdings Inc.; JenaValve Technology Inc.; Meril Life Sciences Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pediatric Heart Valve Repair and Replacement market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Lepu Medical Technology (Beijing) Co. Ltd.
- Edwards Lifesciences Corporation
- Artivion Inc.
- CryoLife Inc.
- LivaNova PLC
- TTK Healthcare Limited
- Braile Biomedica Ltda.
- Micro Interventional Devices Inc.
- Xeltis AG
- Auto Tissue Berlin GmbH
- BioStable Science and Engineering Inc.
- Colibri Heart Valve LLC
- Valcare Medical
- Symetis SA
- On-X Life Technologies Holdings Inc.
- JenaValve Technology Inc.
- Meril Life Sciences Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.56 Billion |
| Forecasted Market Value ( USD | $ 3.97 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
